3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
5
Neoplasm Metastasis
4
Colonic Neoplasms
4
Prostatic Neoplasms
3
Rectal Neoplasms
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Hyperthermia
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Ovarian Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Metabolic Syndrome
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Interventions
Ropivacaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Morphine
5
Acetaminophen
5
Saline Solution
4
Lidocaine
4
Ketamine
4
Fentanyl
4
Sodium Chloride
3
Dexmedetomidine
3
Bupivacaine
3
Anesthetics, Local
3
Anesthesia, Local
3
Acupuncture Therapy
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
parecoxib
2
Transcutaneous Electric Nerve Stimulation
2
Tramadol
2
Therapeutics
2
Tea
2
Surveys and Questionnaires
2
Propofol
2
Oxycodone
2
Magnesium Sulfate
2
Levobupivacaine
2
Control Groups
2
ramosetron
1
acetaminophen, codeine drug combination
1
Varenicline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Agnosia
×
Diathermy
×
Clear all
NCT04778631
2025-11-20
PERISAFE
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
115 enrolled